Cargando…
Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment options include calcium...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045075/ https://www.ncbi.nlm.nih.gov/pubmed/36978831 http://dx.doi.org/10.3390/antiox12030583 |
_version_ | 1784913509087182848 |
---|---|
author | Yu, Lidong Li, Xueting He, Mingyue Wang, Qingchen Chen, Ce Li, Fangshun Li, Bingsheng Li, Li |
author_facet | Yu, Lidong Li, Xueting He, Mingyue Wang, Qingchen Chen, Ce Li, Fangshun Li, Bingsheng Li, Li |
author_sort | Yu, Lidong |
collection | PubMed |
description | Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment options include calcium supplements and iron chelators. However, simple calcium supplementation is not effective, and it does not have a good therapeutic effect. Oxidative stress is one of the triggers for osteoporosis. Therefore, the study focuses on the antioxidant aspect of osteoporosis treatment. The present work revealed that antioxidant carboxymethyl chitosan-based carbon dots (AOCDs) can effectively treat iron overload osteoporosis. More interestingly, the functional modification of AOCDs by doping calcium gluconate (AOCDs:Ca) is superior to the use of any single component. AOCDs:Ca have the dual function of antioxidant and calcium supplement. AOCDs:Ca effectively improve the bioavailability of calcium and achieve ultra-low concentration calcium supplement for the treatment of iron-induced osteoporosis in zebrafish. |
format | Online Article Text |
id | pubmed-10045075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100450752023-03-29 Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish Yu, Lidong Li, Xueting He, Mingyue Wang, Qingchen Chen, Ce Li, Fangshun Li, Bingsheng Li, Li Antioxidants (Basel) Article Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment options include calcium supplements and iron chelators. However, simple calcium supplementation is not effective, and it does not have a good therapeutic effect. Oxidative stress is one of the triggers for osteoporosis. Therefore, the study focuses on the antioxidant aspect of osteoporosis treatment. The present work revealed that antioxidant carboxymethyl chitosan-based carbon dots (AOCDs) can effectively treat iron overload osteoporosis. More interestingly, the functional modification of AOCDs by doping calcium gluconate (AOCDs:Ca) is superior to the use of any single component. AOCDs:Ca have the dual function of antioxidant and calcium supplement. AOCDs:Ca effectively improve the bioavailability of calcium and achieve ultra-low concentration calcium supplement for the treatment of iron-induced osteoporosis in zebrafish. MDPI 2023-02-26 /pmc/articles/PMC10045075/ /pubmed/36978831 http://dx.doi.org/10.3390/antiox12030583 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Lidong Li, Xueting He, Mingyue Wang, Qingchen Chen, Ce Li, Fangshun Li, Bingsheng Li, Li Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish |
title | Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish |
title_full | Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish |
title_fullStr | Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish |
title_full_unstemmed | Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish |
title_short | Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish |
title_sort | antioxidant carboxymethyl chitosan carbon dots with calcium doping achieve ultra-low calcium concentration for iron-induced osteoporosis treatment by effectively enhancing calcium bioavailability in zebrafish |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045075/ https://www.ncbi.nlm.nih.gov/pubmed/36978831 http://dx.doi.org/10.3390/antiox12030583 |
work_keys_str_mv | AT yulidong antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT lixueting antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT hemingyue antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT wangqingchen antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT chence antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT lifangshun antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT libingsheng antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish AT lili antioxidantcarboxymethylchitosancarbondotswithcalciumdopingachieveultralowcalciumconcentrationforironinducedosteoporosistreatmentbyeffectivelyenhancingcalciumbioavailabilityinzebrafish |